COVID-19 vaccine and booster hesitation around the world: A literature review

被引:35
|
作者
Shah, Aashka [1 ]
Coiado, Olivia C. [1 ,2 ]
机构
[1] Univ Illinois, Carle Illinois Coll Med, Urbana, IL 61820 USA
[2] Univ Illinois, Dept Biomed & Translat Sci, Urbana, IL USA
关键词
COVID-19; vaccine hesitancy; vaccination education; COVID-19 booster vaccine; global vaccine literacy; COVID-19 vaccination rate; COVID-19 booster rates; SARS-COV-2; INFECTION; INFORMATION; HESITANCY; IMMUNITY;
D O I
10.3389/fmed.2022.1054557
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The development of COVID-19 vaccines has helped limit the extent of the pandemic, which over the past 2 years has claimed the lived of millions of people. The Moderna and Pfizer COVID-19 vaccines were the first to be manufactured using mRNA technology. Since then, other manufacturers have built their own vaccines which utilize adenovirus vector, whole inactivated coronavirus, and protein subunit methods. Given the continued mutation of the SARS-CoV-2 virus, a booster of the COVID-19 vaccine offers additional protection for citizens, especially those with comorbid conditions. However, uptake of the vaccine and booster has faced hurdles. This literature review aims to analyze the acceptance of the COVID-19 booster among different populations throughout the world. Keywords searched include "COVID-19 vaccine rates OR COVID-19 booster rates," "COVID-19 vaccine hesitancy," "COVID-19 booster hesitancy," "reasons against COVID-19 vaccine," "reasons for COVID-19 vaccine," and "COVID-19 vaccine acceptance" (for each country). Research articles indexed in PubMed, University of Illinois Urbana-Champaign Library, and Google Scholar were included. Despite the proven effectiveness of the COVID-19 booster, vaccine hesitancy is still causing suboptimal compliance to the primary vaccine and booster, thus slowing down control of the pandemic. Reasons for vaccine hesitancy differ by country and acceptance is affected by misinformation, political circumstances, and cultural values. Among the most common reasons found are distrust in the government, a lack of safety information, and fear of side effects. Uptake of the COVID-19 vaccine has also been delayed in low and middle income countries due to resource allocation and as a result, these countries have fallen behind vaccination benchmarks. The future of COVID-19 vaccination is unknown, but vaccine mandates and additional booster doses are a possibility. Determining the ethical impact that these policies could have will allow for the best implementation.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] COVID-19 booster vaccine willingness
    Sonderskov, Kim Mannemar
    Vistisen, Helene Tilma
    Dinesen, Peter Thisted
    Ostergaard, Soren Dinesen
    DANISH MEDICAL JOURNAL, 2022, 69 (01):
  • [2] COVID-19 vaccine hesitation and brand choice uncertainty
    Rodrigues, Paula
    Borges, Ana Pinto
    Brochado, Ana
    Sousa, Ana
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL AND HEALTHCARE MARKETING, 2023, 17 (04) : 495 - 516
  • [3] Spain's Hesitation at the Gates of a COVID-19 Vaccine
    Eguia, Hans
    Vinciarelli, Franco
    Bosque-Prous, Marina
    Kristensen, Troels
    Saigi-Rubio, Francesc
    VACCINES, 2021, 9 (02) : 1 - 8
  • [4] COVID-19 vaccine related menstrual irregularities: A cause of vaccine hesitation?
    Saleem, Aqsa
    Javed, Syed Owais
    Malik, Farheen
    JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2022, 72 (08) : 1683 - 1684
  • [5] Leukopenia associated with lamotrigine initiation after COVID-19 vaccine booster: A case report and literature review
    Murata, Tsukasa
    Uno, Katsuaki
    Ito, Miki
    Nagamine, Takahiko
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2024, 62 (01) : 48 - 55
  • [6] Novavax COVID-19 Vaccine Booster Authorized
    Larkin, Howard D.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 328 (21): : 2101 - 2101
  • [7] Predicting COVID-19 booster vaccine intentions
    Hagger, Martin S.
    Hamilton, Kyra
    APPLIED PSYCHOLOGY-HEALTH AND WELL BEING, 2022, 14 (03) : 819 - 841
  • [8] COVID-19 vaccine equity and booster doses
    LANCET INFECTIOUS DISEASES, 2021, 21 (09): : 1193 - 1193
  • [9] Evaluation of COVID-19 Booster Vaccine Effectiveness
    Qu, Bingqian
    Zhang, Dingmei
    VIRUSES-BASEL, 2025, 17 (02):
  • [10] COVID-19 Vaccine Booster: To Boost or Not to Boost
    Shekhar, Rahul
    Garg, Ishan
    Pal, Suman
    Kottewar, Saket
    Sheikh, Abu Baker
    INFECTIOUS DISEASE REPORTS, 2021, 13 (04) : 924 - 929